Fennec Pharmaceuticals Inc. held its Annual General and Special Meeting of Shareholders on June 3, 2025. During the meeting, the election of directors was approved. Additionally, the appointment of Haskell & White LLP as auditors and the authorization for directors to fix the auditor remuneration were approved. Certain amendments to the 2020 Equity Incentive Plan were also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9462738-en) on June 03, 2025, and is solely responsible for the information contained therein.